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Female Genital Mutilation (FGM), also called
Female Circumcision or more neutrally Female
Genital Cutting, is defined as a procedure involv-
ing partial or total removal of the external female
genitalia or injury to the female genital organs
whether for cultural or other non therapeutic rea-
sons [1]. It is performed traditionally in sub-Saha-
ran countries with prevalence rates varying from 5
to 98% [1]. WHO estimates that some 100–140
million women have experienced FGM and that
approximately two million girls are at risk of
undergoing the procedure every year [2]. 
The form of FGM performed varies from one
ethnic group to another. It can involve the excision
of the prepuce with or without excision of part or
all of the clitoris (Type I), additional partial or total
excision of the labia minora (Type II), or infibula-
tion (Type III) which implies excision of the ex-
ternal genitalia and closing of the vagina leaving
only a small opening. This form is observed in 15%
of the affected women [3] and is traditionally per-
formed in certain parts of Egypt, Eritrea, North-
ern Kenya, Mali, Ethiopia and nearly all of Soma-
lia, Djibouti and Northern Sudan [2]. Health con-
sequences vary depending on the degree of cutting
and are most severe in case of infibulation. Imme-
diate complications include severe pain, infections,
haemorrhage, urine retention, injuries to neigh-
bouring organs and even death. Long term conse-
quences such as dermal cysts, scar neuromas, re-
peated urinary and reproductive tract infections,
sterility, dysmenorrhoea and psychological prob-
lems are possible. In the case of infibulation, com-
plications during labour and delivery can also
occur [1]. Through migration, European countries
and their health services have been increasingly
confronted with FGMs and their medical conse-
quences [4–6].
The aim of this study was to evaluate the situ-
ation concerning FGM in Switzerland, focusing
on how and to what extent Swiss gynaecologists are
confronted with the issue of FGM. The attitude of
health authorities and the pre-graduate curricula
in medical schools were also evaluated.
Question under study: To evaluate the situation
of Female Genital Mutilation (FGM) in Switzer-
land.
Methods: Through a questionnaire, Swiss
gynaecologists were asked if they have been con-
fronted to FGMs, if they have had requests to
perform reinfibulations and FGMs. The health
representatives (Kantonsärzte / médecins can-
tonaux) were interviewed on FGM activity at the
Canton level. Swiss Medical Schools were asked if
FGM was included in the pregraduate curriculum,
and an estimated prevalence rate for FGMs in
Switzerland was calculated.
Results: Among Swiss gynaecologists, 20% re-
ported having been confronted with patients pre-
senting with FGM and among them 40% had been
asked about reinfibulation. Gynaecologists are oc-
casionally asked about the possibility of perform-
ing FGMs in Switzerland. No activity concerning
FGM is reported by health authorities in the Can-
tons. Teaching about FGM is not included in the
curriculum of any of the Swiss medical schools.
Approximately 6,700 girls at risk and women who
have undergone FGM live in Switzerland. 
Conclusion: The extent to which gynaecologists
are confronted to women with FGM may justify
further action to try to better understand the situ-
ation in Switzerland. Improvement of care by
proper education of health care providers (guide-
lines) and prevention of new cases by women’s
education should also be considered.
Key words: female genital mutilation; female cir-
cumcision; Switzerland; reinfibulation; prevalence
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Summary
Introduction
In order to evaluate the situation of FGM in Switzer-
land, the Swiss Society of Gynaecology and Obstetrics in
association with the Swiss Committee for UNICEF sent
a questionnaire containing five questions to all its mem-
bers. A total of 1,162 questionnaires were sent out in
March 2001 and had to be returned by the end of April
2001.
The questions asked were as follows:
1. Have you already been confronted with a patient pre-
senting with FGM? 
2. In cases of infibulation: have you been asked to perform
reinfibulation after delivery?
3. Have you already been asked to perform FGM on a girl
or a young woman?
4. Have you been asked about the possibility of perform-
ing FGM in Switzerland? 
5. Have you heard of FGMs being performed in Switzer-
land?
Answers were examined according to the total popu-
lation studied and the respondents. For the analysis ac-
cording to the different Cantons, only those providing
their address were taken into account (n = 340). The Can-
tons of Schwyz, Uri, Obwalden and Nidwalden were
regrouped under the heading: Central Switzerland. The
data were analysed using Fisher’s exact tests.
The five Swiss medical schools having clinical curric-
ula were asked if FGM was a topic in their curriculum. The
health representatives of the Swiss cantons (Kantons-
ärzte/Médecins cantonaux) were contacted in November
2001. The following questions were asked:
1. Are guidelines available? 
2. Is there a reporting system for FGMs in your Canton?
3. As a health official, have you been confronted with the
problem? 
4. Are you aware of any activities at the Canton level?
The number of individuals (girls at risk and women
presenting with FGM) living in Switzerland was evaluated
by multiplying the number of females from countries
where FGMs are traditionally performed with the specific
countries’ prevalence rates for FGM. The Swiss Federal
Statistics Office and the Federal Office for Refugees pro-
vided figures on foreign population and refugees. 
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Methods
Results
Among the 1,162 questionnaires, 454 were
returned (39.1% responding rate), including
114 anonymous answers. Two hundred and thirty-
three gynaecologists stated having been con-
fronted with patients presenting with FGMs. This
is equal to 51.3% of the respondents and 20.0% of
the whole population studied. Significantly higher
Yes responding rates were found in Western
Swiss Cantons number of confrontation response confrontation rate demand for reinfibulation
specialists rate rate among respondents among respondents
Aargau 70 5.7% 21.4% 26.7% 75.0%
Appenzell 6 0.0% 33.3% 0.0% –
Berne 155 20.6% 35.5% 58.2% 37.5%
Basel-Country 37 13.5% 18.9% 71.4% 80.0%
Basel-City 69 10.1% 15.9% 63.6% 42.9%
Central Switzerland 18 27.8% 50.0% 55.6% 100.0%
Fribourg 29 24.1% 34.5% 70.0% 0.0%
Geneva 104 25.0% 33.7% 74.3% 61.5%
Glarus 7 14.3% 14.3% 100.0% 100.0%
Graubünden 20 20.0% 35.0% 57.1% 25.0%
Jura 10 20.0% 50.0% 40.0% 50.0%
Lucerne 44 20.5% 29.5% 69.2% 55.6%
Neuchâtel 28 42.9% 46.4% 92.3% 50.0%
St. Gallen 55 16.4% 23.6% 69.2% 22.2%
Schaffhausen 15 20.0% 40.0% 50.0% 66.7%
Solothurn 23 21.7% 52.2% 41.7% 40.0%
Thurgau 26 11.5% 30.8% 37.5% 66.7%
Ticino 49 8.2% 18.4% 44.4% 50.0%
Vaud 119 21.0% 31.1% 67.6% 52.0%
Valais 27 33.3% 40.7% 81.8% 22.2%
Zug 15 6.7% 13.3% 50.0% 0.0%
Zurich 236 16.1% 25.0% 64.4% 34.2%
Total*/Overall Rates 1162 20.0% 39.0% 51.3% 40.7%
Table 1
Confrontation rates
for FGM among
Swiss Gynaecolo-
gists (*total number
includes 114 anony-
mous answers).
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Figure 1
Confrontation rates for FGM among Swiss
Gynaecologists according to the different
Cantons.
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Country of origin estimated asylum seekers permanent totals estimated number of girls 
prevalence or related residents at risk and women who 
of FGM underwent FGM
Benin 50% 4 51 55 27
Burkina Faso 72% 8 69 77 55
Cameroon 20% 115 1128 1243 249
Central African Rep. 43% 2 11 13 6
Chad 60% 1 28 29 17
Djibouti 98% 0 7 7 7
Egypt 97% 4 540 544 528
Eritrea 95% 333 312 645 613
Ethiopia 85% 649 505 1154 981
Gambia 80% 0 19 19 15
Ghana 30% 9 567 576 173
Guinea 99% 26 66 92 91
Guinea-Bisau 50% 2 11 13 7
Ivory Coast 43% 26 457 483 208
Kenya 38% 11 531 542 206
Liberia 60% 8 54 62 37
Mali 94% 2 42 44 41
Mauritania 25% 2 15 17 4
Niger 5% 0 15 15 1
Nigeria 25% 49 294 343 86
Senegal 20% 7 330 337 67
Sierra Leone 90% 35 38 73 66
Somalia 98% 2147 739 2886 2828
Sudan 89% 39 193 232 206
Tanzania 18% 3 120 123 22
Togo 12% 46 126 172 21
Uganda 5% 3 162 165 8
Yemen 23% 83 38 121 28
Zaire 5% 925 1333 2258 113
Totals 4539 7801 12 340 6711
Table 2
Estimated number 
of girls at risk and
women who under-
went FGM according
to WHO Prevalence
Rates 2001 [3] (num-
bers do not include
women holding a
Swiss passport).
Switzerland where 81/317 gynaecologists had
been confronted with women presenting with
FGMs, as compared to 130/845 (15.4%) for the
rest of Switzerland (p <0.0001). This corresponds
to 25.5% of all gynaecologists in the French speak-
ing part of Switzerland and 73% of the respon-
dents in that region. A maximum was observed in
the Swiss Canton of Neuchâtel where 42.9% of all
gynaecologists (92.3% of the respondents) had
already treated women presenting with FGMs,
followed by Valais with 33% (table 1). The re-
maining French Cantons, Berne, Solothurn and
Lucerne together with the Central part of Switzer-
land showed rates of at least twenty percent. The
overall rate for the region of Zurich and Eastern
Switzerland was 16%. Lowest contact rates were
observed in Ticino (8.2%), Zug, Appenzell and
parts of North Western Switzerland (figure 1).
Ninety-five of the 454 respondents had been
asked to perform reinfibulation after delivery. This
corresponds to every fifth respondent (20.9%),
and to 8.2% of the total population studied. It cor-
responds to 40.7% of gynaecologists confronted
with the problem in Switzerland. In most Cantons
of the French part of Switzerland at least 50% of
the gynaecologists confronted with FGM were
asked to perform reinfibulation. High percentages
of gynaecologists confronted with the question of
reinfibulation after delivery were also observed in
Lucerne (55.6%) and in regions with lower con-
tact rates such as Aargau (75.0%), Basel-Country
(80.0%), Ticino (50.0%) and Thurgau (66.7%). 
As for the possibility of performing FGM on
girls, two gynaecologists reported having been
asked to do so. When asked if they have been con-
fronted with the question of where FGMs can be
performed in Switzerland four gynaecologists gave
a positive answer. Twelve respondents had heard of
FGMs being performed in Switzerland.
In the 5 Swiss Medical schools, FGM is not in-
cluded in the pre-graduate curriculum. None of
the Cantons’ health representatives knew about
existing guidelines in their Canton. No reporting
system exists. Only two have been confronted with
problems related to FGM. One concerning the re-
quest of a family to circumcise both their son and
their daughter, and the other by the police asking
if medical precautions were necessary as a family
had requested using school rooms to perform fe-
male circumcision. No activities concerning FGM
were reported from any of the Health Depart-
ments.
An estimated 6,711 girls at risk and women
who had undergone FGM live in Switzerland,
3,499 as permanent residents and 3,212 asking for
political asylum or related procedures (table 2).
More than one third (2,828) are of Somali origin,
thus from a region where FGM is performed in
nearly 100% of women. These numbers do not in-
clude women holding a Swiss passport.
Female genital mutilation in Switzerland 262
Discussion
Very little information is available on FGM in
Switzerland. In 1991 the number of women at risk
or affected by FGM was estimated to be 1,951 [7].
Presently it is estimated to be approximately 6,700,
but these numbers do not allow conclusions to be
drawn on how the Swiss health care system is con-
fronted with the issue. This study showed that one
fifth (20%) of all Swiss gynaecologists (51% of re-
spondents) had been confronted with patients pre-
senting with FGMs. The responses showed that
gynaecologists all over Switzerland were con-
fronted with FGMs. The higher prevalence in the
French speaking part of Switzerland could be ex-
plained by the fact that French is spoken in many
sub-Saharan countries, although this does not
apply for other groups such as the Somalis.
Most of the gynaecologists were probably con-
fronted with infibulation, as Type I and II often go
unnoticed [8]. Management of related health
problems may be difficult. While the excision of a
dermoid cyst in case of Type I circumcision may be
rather simple [9], gynaecologists may face difficul-
ties in obtaining cervical smears or performing
vaginal examinations if the introitus is too narrow
[8,10,11]. After delivery, obstetricians have to deal
with the repair of the vulva, which in case of pre-
vious infibulation can be performed in order to re-
store normal vulva opening whereas reinfibula-
tion, responsible for medical complications, is
practised in the women’s country of origin.
Women may find an “exposed vulva” unaccept-
able, and sometimes insist on reinfibulation argu-
ing this is part of their identity and will ensure her
husband’s fidelity and sexual satisfaction [12–14].
The British College of Obstetricians and Gynae-
cologists recommends that surgery can be per-
formed for purposes connected with labour or
birth, but that it is illegal to repair the labia inten-
tionally in such a way that intercourse is difficult
or impossible. According to these recommenda-
tions, surgery may be performed for mental health
reasons, but not as a matter of custom or ritual [15].
There is no official guideline in Switzerland and
the legal aspects have yet to be clarified.
This study showed that among Swiss gynae-
cologists confronted with FGM, 40.7% had been
asked about the possibility of performing some
form of reinfibulation. In a study among 432 So-
mali women in Canada, 1/3 thought their husband
should take the decision and 1/5 declared it was the
obstetrician’s responsibility [16]. Approximately
2/3 reported that their husband would not favour
reinfibulation. This shows that husbands should be
involved in the discussion and that doctors’ influ-
ence may be important. The timing of counselling
may have an impact as well. If a patient is con-
fronted for the first time with the issue in the
labour ward, she will probably find it more diffi-
cult to agree to a practice that is foreign to her and
is contradictory to her tradition. Specifically
trained health workers should discuss the issue
during the prenatal period, as specialised clinics
seem to be less confronted with the demand for
reinfibulation [5]. 
During pregnancy, the timing for defibulation
remains controversial. Defibulation in the second
trimester has been suggested [17] in order to avoid
acute problems during delivery: when on call staff
might not be familiar with the problem. Moreover,
vaginal examination at the beginning of labour
might be easier. Finally, it could help reduce blood
loss at delivery and decrease the risk of transmis-
sion of infectious diseases. We think this procedure
is almost never necessary, since it would mean ad-
ditional surgery and anaesthesia during pregnancy,
while other authors have shown that there was no
difference in terms of labour duration, rates of epi-
siotomy or vaginal tears, amount of blood loss,
APGAR scores or hospital stay [18].
The fact that two gynaecologists have been
asked to perform FGMs on girls and that four have
been asked if they could provide information on
where FGM could be performed in Switzerland
shows a certain demand. No case of FGM has yet
been brought to court in Switzerland but twelve
gynaecologists have heard of FGMs performed in
Switzerland. Law suits in France [4] show that girls
are also affected in Europe and it may be unrealis-
tic to believe that an immigrant population is ready
to give up this tradition, especially as it can be a
source of identification in a foreign setting [19]. It
should not be forgotten that the parents who have
their daughters circumcised according to their tra-
ditions do so with best intentions. Many circum-
cised women do not see a link between possible
health problems and circumcision and do not con-
sider circumcision as a mutilation, expressing pos-
itive feelings towards it [16]. Some may also hope
to protect their daughters growing up in a West-
ern society. Immigrants may not understand the
special interest paid to FGM [20], especially as
they may be confronted to other more acute prob-
lems [20] upon arrival in a foreign country. Those
in Switzerland not ready to abandon this tradition
may either leave the country to have it performed
during a trip back home [21], or be forced to go
underground and thus try to avoid medical treat-
ment when complications occur. In using a harm
reducing approach, a medicalisation of the practice
had been proposed in the USA in 1996. The Seat-
tle compromise involved only nicking the clitoral
prepuce to draw a single drop of blood under
anaesthesia, to offer a less harmful solution [15].
This is clearly rejected by WHO [22] which con-
demns all forms of FGMs in order not to hinder
the eradication of the practice, whereas others [15]
recommend careful consideration of the conse-
quences of various forms of medicalisation in order
to evaluate whether it has the potential to reduce
harm and serve as an engine of change.
Several African countries such as Burkina
Faso, Central Africa Republic, Ivory Coast, Dji-
bouti, Ghana Guinea, Tanzania, Togo and Senegal
have passed laws against FGM [3]. Britain, Swe-
den, Norway, Belgium [6] and the US [23] have
specific laws against FGM. In Switzerland, Art.
122 of the Penal Code and the Swiss Academy for
Medical Sciences [24] condemn FGM, and in 2000
the Swiss Federal Government wanted to increase
attention paid to FGM [19]. In 2001, the European
Parliament Women’s Rights Committee adopted a
report asking for further action in the EU [6]. In
Africa [25, 26] as well as in Western countries [5,
16, 27] many are ready to abandon the tradition.
These people need to be supported and may be a
key to the change of attitudes of their fellow coun-
trymen. Immigrant women who gave up FGM
should be considered as partners. Trained as me-
diators they can deal with this culturally sensitive
issue, are not considered as intruders, and are more
likely to be trusted.
The fact that only two Canton health repre-
sentatives have been confronted with problems re-
garding FGMs may explain why it is often consid-
ered a non-medical issue and no activity seems to
be carried out by Health Departments. On the
other hand, physicians can play a key role in pre-
vention since they have a closer contact [12] with
the affected group than any other professional
group. When facing FGM, physicians are not only
confronted to a legal and medical issue but also to
an ethically and culturally sensitive issue. Facing
the results of a practice they probably condemn as
a mutilation, health care workers’ reactions may
even be a source of added humiliation for the
patients [21]. As medical aspects are strong
arguments against FGM and as management 
of affected women may be difficult, guidelines 
for health personnel are needed and teaching of
FGM should be included in medical school
curricula because the problem may concern fam-
ily doctors in the first place. In a study among
physicians in the European Union, 78% said they
would welcome a code of conduct [28]. Such
guidelines are being developed in several Euro-
pean countries and already exist on a national level
in England and Norway [29, 30]. They could easily
be adapted for Switzerland. Fact sheets providing
useful information and addresses should also be
made available. 
Compared to other health problems, FGM
may not seem very frequent. Considering that ap-
proximately every fifth gynaecologist in Switzer-
land has treated patients presenting FGM, that
40% of them are facing delicate questions such as
reinfibulation, that there are hints that FGM
might be performed in Switzerland, further action
is justified to try to better understand the situation
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in this country and prevent the occurrence of new
cases. Improvement of care by proper education of
health care providers and prevention of new cases
by women’s education should also be considered. 
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